Table 1.
Demographic and behavioral characteristics among non-pregnant, sexually active women enrolling at ISS Clinic, Mbarara Uganda, during 2009.
| Total n (col%) | |
|---|---|
| All | 826 (100.0) |
| Demographics | |
| Age (years) (median (IQR)) | 29 (24–35) |
| 18–24 | 211 (25.5) |
| 25–29 | 206 (25.0) |
| 30–35 | 234 (28.3) |
| 36–39 | 175 (21.2) |
| Education | |
| None | 0 (0.0) |
| Primary level | 453 (54.8) |
| Secondary | 148 (17.9) |
| Tertiary | 64 (7.8) |
| Missing | 161 (19.5) |
| Marital status | |
| Married | 398 (48.5) |
| Previously married (separated, divorced, or widowed) | 348 (42.4) |
| Not married | 75 (9.1) |
| Tribe | |
| Kiga | 81 (9.8) |
| Nkole | 596 (72.2) |
| Other | 109 (13.2) |
| Missing | 40 (4.8) |
| Religion | |
| Catholic | 246 (29.8) |
| Protestant | 419 (50.7) |
| Muslim | 83 (10.0) |
| Other | 22 (2.7) |
| Missing | 56 (6.8) |
| Monthly income (USH) | |
| <100,000 | 575 (69.7) |
| 100,000–250,000 | 73 (8.8) |
| >250,000 | 16 (1.9) |
| Missing | 162 (19.6) |
| Among married persons: HIV status of spouse | |
| Negative | 21 (5.3) |
| Positive | 281 (70.6) |
| Unknown | 70 (17.6) |
| Missing | 26 (6.5) |
| Among married persons: HIV status disclosure | |
| Disclosed to spouse | 279 (70.1) |
| Disclosed to someone but not to spouse | 48 (12.6) |
| No disclosure reported | 71 (17.8) |
| Among un-married persons: HIV status disclosure | |
| Disclosed to sexual partner | 13 (3.1) |
| Disclosed to others but not to sexual partner | 301 (71.2) |
| No disclosure reported | 109 (25.8) |
| Health status | |
| WHO clinical stage* | |
| Stage 1 or 2 | 526 (63.7) |
| Stage 3 or 4 | 200 (24.2) |
| Missing | 100 (12.1) |
| CD4 cell count (/mm3) | |
| ≤200 | 219 (26.5) |
| 201–350 | 149 (18.0) |
| 351–500 | 115 (14.0) |
| >500 | 205 (24.8) |
| Missing | 138 (16.7) |
| Number of living biological children | |
| 0 children | 39 (4.7) |
| 1-2 children | 208 (25.2) |
| 3 or more children | 186 (22.5) |
| Missing | 393 (47.6) |
| Type of contraceptive method used | |
| None | 596 (72.2) |
| Condoms | 68 (8.2) |
| Oral contraceptives | 20 (2.4) |
| Injectable hormones | 119 (14.4) |
| Norplant | 0 (0.0) |
| Natural family planning/rhythm method | 7 (0.9) |
| Intrauterine device | 1 (0.1) |
| Sterilization | 5 (0.6) |
| Diaphragm | 2 (0.2) |
| Other | 3 (0.4) |
| Condom use + another method | 5 (0.6) |
*WHO clinical stage refers to the World Health Organization clinical staging for HIV disease based on symptoms, signs and diagnosed opportunistic infections in clients with HIV infection. Stages 1 and 2 are considered asymptomatic or mild disease, while stages 3 and 4 are considered severe disease and patients in these categories should begin antiretroviral therapy.